APYX (Apyx Medical Corporation) Total Enterprise Value
Apyx Medical (APYX) develops innovative helium plasma-based systems for plastic surgery. This price chart reflects R&D investments and the development of tissue coagulation, with an Enterprise Value of 117.76. Proprietary rejuvenation methods allow the brand to maintain high profitability by bypassing standard electrosurgical devices. Equipment assembly and global logistics are outsourced to third-party contractors to ensure the efficient servicing of clinics.
Financial and market metric breakdowns for Apyx Medical Corporation (APYX)
Enterprise Value combines market capitalization and net debt to determine the total price for acquiring a business. This metric allows an investor to assess the actual costs of buying all assets while accounting for liabilities. The trend in the real buyout value of a business reflects market expectations regarding the company's valuation. For Apyx Medical (APYX), this indicator is critical due to its dependence on external electronics suppliers. The EV valuation helps determine the extent to which the company's capital covers risks associated with component outsourcing.